- Home
- PPSI vs NSRX Comparison
PPSI vs NSRX Comparison
Compare PPSI & NSRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PPSI | NSRX |
|---|---|---|
| Founded | 2008 | 2019 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Electrical Products | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 51.4M | 52.5M |
| IPO Year | N/A | 2025 |
Fundamental Metrics
Financial Performance| Metric | PPSI | NSRX |
|---|---|---|
| Price | $4.04 | $5.90 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | $12.00 | ★ $20.50 |
| AVG Volume (30 Days) | ★ 149.4K | 4.5K |
| Earning Date | 11-13-2025 | 03-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 2.86 | N/A |
| Revenue | ★ $31,751,000.00 | N/A |
| Revenue This Year | $26.84 | N/A |
| Revenue Next Year | $10.26 | N/A |
| P/E Ratio | $1.43 | ★ N/A |
| Revenue Growth | ★ 105.82 | N/A |
| 52 Week Low | $2.25 | $4.90 |
| 52 Week High | $5.70 | $9.99 |
Technical Indicators
Market Signals| Indicator | PPSI | NSRX |
|---|---|---|
| Relative Strength Index (RSI) | 38.66 | 39.97 |
| Support Level | $3.87 | $4.90 |
| Resistance Level | $4.48 | $6.30 |
| Average True Range (ATR) | 0.32 | 0.42 |
| MACD | -0.07 | -0.02 |
| Stochastic Oscillator | 5.05 | 34.46 |
Price Performance
Historical ComparisonAbout PPSI Pioneer Power Solutions Inc.
Pioneer Power Solutions Inc designs, manufactures, integrates, services, and sells distributed energy resources, on-site and mobile power generation equipment, and a platform of mobile electric vehicle (EV) charging solutions.. Its principal products and services include custom-engineered electrical transformers, switchgear and engine-generator sets and controls, complemented by a national field-service network to maintain and repair power generation assets.
About NSRX Nasus Pharma Ltd. Ordinary Shares
Nasus Pharma Ltd is a clinical-stage specialty pharmaceutical company focused principally on the development of intranasal drugs to treat emergency medical conditions. It is engaged in developing a number of intranasal powder products based on its a microsphere technology, aimed at assisting patients in several acute emergency situations such as opioid overdose and anaphylactic shock. Its portfolio comprises a number of programs: Intranasal Naloxone completed pivotal study and Intranasal Epinephrine (phase 2) as well as a number of preclinical POC programs.